Insights into ongoing research on BTK degraders for lymphoid malignancies

Insights into ongoing research on BTK degraders for lymphoid malignancies

BTK Degrader Offers Promise in Relapsed and Refractory CLLПодробнее

BTK Degrader Offers Promise in Relapsed and Refractory CLL

Insights into the activity of NX-2127 in patients with R/R B-cell malignanciesПодробнее

Insights into the activity of NX-2127 in patients with R/R B-cell malignancies

Mechanism of action of BTK degraders and insights into NX-5948Подробнее

Mechanism of action of BTK degraders and insights into NX-5948

The potential of BGB-16673, a BTK degrader, for the treatment of R/R B-cell malignanciesПодробнее

The potential of BGB-16673, a BTK degrader, for the treatment of R/R B-cell malignancies

Novel BTKi strategies in indolent B-cell malignancies: pirtobrutinib for FL and MZLПодробнее

Novel BTKi strategies in indolent B-cell malignancies: pirtobrutinib for FL and MZL

discovery of NX-2127, a BTK degrader for B-cell malignanciesПодробнее

discovery of NX-2127, a BTK degrader for B-cell malignancies

Advances in non-covalent BTK inhibitors for CLL: BRUIN study updateПодробнее

Advances in non-covalent BTK inhibitors for CLL: BRUIN study update

Platysma Muscle Suture/No Suture After Thyroid Surgery | BTK/RASACS Journal Club #27Подробнее

Platysma Muscle Suture/No Suture After Thyroid Surgery | BTK/RASACS Journal Club #27

Chronic lymphocytic leukemia (CLL): Advances in research & treatment: 2024 Leukemia Conference, LLSCПодробнее

Chronic lymphocytic leukemia (CLL): Advances in research & treatment: 2024 Leukemia Conference, LLSC

BRUIN study update: analysis of the mechanisms of resistance to pirtobrutinib in CLLПодробнее

BRUIN study update: analysis of the mechanisms of resistance to pirtobrutinib in CLL

Chronic Lymphocytic Leukaemia (CLL) - New Study ResultsПодробнее

Chronic Lymphocytic Leukaemia (CLL) - New Study Results

How does the architecture of a protein help to block infections?Подробнее

How does the architecture of a protein help to block infections?

Characterization Of Protein & Metabolite Corona Acquired By Nanomaterials l Protocol PreviewПодробнее

Characterization Of Protein & Metabolite Corona Acquired By Nanomaterials l Protocol Preview

Predicting patient response to BTK inhibitors using novel approachesПодробнее

Predicting patient response to BTK inhibitors using novel approaches

“What’s New in Basic and Translational Research," by Dr. Dawn QuelleПодробнее

“What’s New in Basic and Translational Research,' by Dr. Dawn Quelle